Material Type

• Blood (whole) (1)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Pathogen DNA (Derivative) (1)
• Plasma (single spun) (1)
• Saliva (1)
• Serum (2)
• Solid tissue (non viable) (1)
• Stool (1)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Affected (1)
• Not applicable (3)

Storage Temperature

• RT (1)
• -35°C to -18°C (1)
• -85°C to -60°C (4)
• Liquid nitrogen (1)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (3)
• Followup records (2)
• Freezer temperature logs (2)
• Genomic datasets (1)
• Microbiological results (1)
• Physiological/biochemical measurements (1)
• Pre-analytical data (3)
• Quality indicators (1)
• Survey data (2)
• Treatment records (2)

Timeframe

• Immediate (1)
• 0 - 3 months (3)
• 3 - 6 months (2)
• > 6 months (4)

Participant Count

• 11 - 100 (4)

Sex

• Both sexes (4)

Age Range

• Infant (1 month - 2 years) (1)
• Young child (2 - 6 years) (1)
• Adolescent (12 - 18 years) (2)
• Adult (> 40 years) (2)

Biobank Services

• Ability to recontact (1)
• Cell culture (1)
• Digital imaging (1)
• Immunohistochemistry - staining (1)
• Nucleic acid extraction (2)

Collection Type

• Cohort (1)
• Cross-sectional (1)
• Disease specific (1)

Consent Restriction

• No Commercial restriction (4)
• No Disease area restriction (3)
• No Genetic analysis restriction (3)
• No Human genetic analysis restriction (4)
• No restrictions (0)
• No Project specific restriction (3)
• No Scope of use restriction (2)

Collection Status

• Completed (1)
• In progress (3)

Access Condition

• Open to applicants (2)
• Open in response to specific calls (1)
• Open only through collaboration (1)

Country

• France (1)
• Germany (1)
• India (1)
• Spain (1)

County